Nephrology Forum

Kidney International (1980) 17, 554–567; doi:10.1038/ki.1980.64

Inappropriate antidiuretic hormone secretion of unknown origin

Presentation of the Forum is made possible by grants from Hoechst-Roussel Pharmaceuticals Inc., Smith Kline & French Laboratories, G. D. Searle & Co., Warner-Lambert Pharmaceutical Division, Burroughs Wellcome Company, Geigy Pharmaceuticals Inc., Ciba Pharmaceuticals Inc., and Boehringer Ingel heim Ltd.

Principal Discussant: Manuel Martinez-Maldonado1

1San Juan VA Hospital, San Juan, Puerto Rico, and Peter Bent Brigham Hospital, Boston, Massachusetts

Correspondence: Dr M Martinez-Maldonado, Renal Division, Peter Bent Brigham Hospital, 721 Huntington Ave., Boston, MA 02115 USA

Top

References

  1. Berl T, Anderson RJ, McDonald K, Schrier RW: Clinical disorders of water metabolism. Kidney Int 10:117–132, 1976
  2. Schrier RW, Berl T: Mechanism of effect of alpha adrenergic stimulation with norephinephrine on renal water excretion. J Clin Invest 52:502–511, 1973
  3. McDonald KM, Miller PD, Anderson RJ, Berl T, Schrier RW: Hormonal control of renal water excretion. Kidney Int 10:38–45, 1976 | PubMed | ISI | ChemPort |
  4. Levinsky NG, Davidson DG, Berliner RW: Effects of reduced glomerular filtration on urine concentration in the presence of antidiuretic hormone. J Clin Invest 38:730–740, 1959
  5. Goldsmith C, Beasley HK, Whalley PJ, Rector FC Jr, Seldin DW: The effect of salt deprivation on the urinary-concentrating mechanism in the dog. J Clin Invest 40:2043–2052, 1961
  6. Schrier RW, Berl T: Hyponatremia and related disorders. The Kidney 7:1–5, 1974
  7. Schwartz WB, Bennett W, Curelop S, Bartter FC: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 23:529–542, 1957 | Article | PubMed | ChemPort |
  8. Leaf A, Bartter FC, Santos RF, Wrong O: Evidence in man that urinary electrolyte loss induced by pitressin is a function of water retention. J Clin Invest 32:868–878, 1953
  9. Jaenike JR, Waterhouse O: The renal response to sustained administration of vasopressin and water in man. J Clin Endocrinol 21:231–242, 1961
  10. Davis JO, Howell DS, Hyatt RE: Effect of chronic pitressin administration on electrolyte excretion in normal dogs and in dogs with experimental ascites. Endocrinology 55:409–416, 1954
  11. Levinsky NG, Davidson DG, Berliner RW: Changes in urine concentration during prolonged administration of vasopressin and water. Am J Physiol 196:451–456, 1959 | PubMed | ISI | ChemPort |
  12. Nolph KD, Schrier RW: Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med 49:534–545, 1970
  13. Cooke CR, Turin MD, Walker WG: The syndrome of inappropriate antidiuretic hormone secretion (SIADH): Pathophysiologic mechanisms in solute and volume regulation. Medicine 58:240–251, 1979
  14. Kaye M: An investigation into the cause of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 41:910–926, 1966
  15. Lowance DC, Garfinkel HB, Mattern WD, Schwartz WB: The effect of chronic hypotonic volume expansion on the renal regulation of acid-base equilibrium. J Clin Invest 51:2928–2940, 1972
  16. Cohen JJ, Hulter HN, Smithline N, Melby JC, Schwartz WB: The critical role of the adrenal gland in the renal regulation of acid-base equilibrium during chronic hypotonic expansion. J Clin Invest 58:1201–1208, 1976
  17. Andersson B: Regulation of body fluids. Annu Rev Physiol 39:185–200, 1977
  18. Andersson B, Ericksson L, Fernandez O, Kolmodin C-G, Oltner R: Centrally mediated effects of sodium and angiotensin II on arterial blood pressure and fluid balance. Acta Physiol Stand 85:398–407, 1972
  19. Martinez-Maldonado M, Tsaparas N, Eknoyan G, Suki WN: Renal actions of prostaglandins: comparison with acetylcholine and volume expansion. Am J Physiol 222:1147–1152, 1972
  20. Orloff J, Handler JS, Bergstrom S: Effect of PGE1 on permeability response of toad bladder to vasopressin, theophylline and adenosine 3',5'-monophosphate. Nature 205:397–398, 1965 | Article | PubMed | ChemPort |
  21. Walker LA, Whorton AR, Smigel M, France R, Frolich JC: Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol 235:F180–F185, 1978
  22. Zusman RM, Vinci JM, Bowden RE, Horwitz D, Keiser HR: Effect of indomethacin and adrenocorticotropic hormone on renal function in man: An experimental model of inappropriate antidiuresis. Kidney Int 15:62–70, 1979
  23. Berl T, Raz A, Wald H, Horwitz J, Czackes W: Prostaglandin synthesis inhibition and the action of vasopressin: Studies in man. Am J Physiol 232:F529–F537, 1977
  24. Zusman RM, Keiser HR, Handler JS: Effect of adrenal steroids on vasopressin-stimulated PGE synthesis and water flow. Am J Physiol 234:F532–F540, 1978
  25. Stoff JS, Handler JS, Preston AS, Orloff J: The effect of aldosterone on cyclic nucleotide phosphodiesterase activity in toad urinary bladder. Life Sci 13:545–552, 1973
  26. Schwartz WB, Tassel D, Bartter FC: Further observations on hyponatremia and renal sodium loss probably resulting from inappropriate secretion of antidiuretic hormone. N Engl J Med 262:743–748, 1960
  27. Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DHP: Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med 73:721–729, 1970 | PubMed | ISI | ChemPort |
  28. Miles AI, Needle MA: Fixed hyponatremia with normal responses to varying salt and water intakes. N Engl J Med 284:26–28, 1971
  29. Beck LH: Hypouricemia in the syndrome of inappropriate antidiuretic hormone secretion. N Engl J Med 301:528–530, 1979 | PubMed | ChemPort |
  30. Beardwell CG: Radioimmunoassay of arginine vasopressin in human plasma. J Clin Endocrinol Metab 33:254–260, 1971
  31. Robertson GL, Mahr EA, Athar S, Sinha T: Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52:2340–2352, 1973 | PubMed | ISI | ChemPort |
  32. Baumann G, Lopez-Amor E, Dingman JF: Plasma arginine vasopressin in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med 52:19–24, 1972
  33. Robertson GL: Vasopressin in osmotic regulation in man. Annu Rev Med 25:315–322, 1974
  34. Robertson GL, Shelton RL, Athar S: The osmoregulation of vasopressin. Kidney Int 10:25–37, 1976 | PubMed | ISI | ChemPort |
  35. DeFronzo RA, Goldberg M, Agus ZS: Normal diluting capacity in hyponatremic patients: Reset osmostat or a variant of SIADH. Ann intern Med 84:538–542, 1976
  36. Michelis MF, Fusco RD, Bragdon RW, Fields JF, Davis BB: Reset of osmoreceptors in association with normovolemic hyponatremia. Am J Med Sci 267:267–273, 1974
  37. Humes HD, Narins RG, Brenner BM: Disorders of water balance. Hasp Pract 14:133–145, 1979
  38. Fanestil DD: Hypoosmolar syndromes, in Disturbances in Body Fluid Osmolality, edited by Andreoli T, Grantham JJ, Rector FC Jr, American Physiological Society, 1977, pp. 267–284
  39. DeRubertis FR Jr, Michelis MF, Bloom ME, Mintz DH, Field JB, Davis BB: Impaired water excretion in myxedema. Am J Med 51:41–53, 1971
  40. Emmanouel DS, Lindheimer MD, Katz AI: Mechanism of impaired water excretion in the hypothyroid rat. J Clin Invest 54:926–934, 1974 | PubMed | ChemPort |
  41. DiScala VA, Kinney MJ: Effects of myxedema on the renal diluting and concentrating mechanism. Am J Med 50:325–335, 1971
  42. Ahmed ABJ, George BC, Gonzalez-Auvert C, Dingman JF: Increased plasma arginine vasopressin in clinical adrenocortical insufficiency and its inhibition by glucosteroids. J Clin Invest 46:111–123, 1967
  43. Aubrey RH, Nankin HR, Moses AM, Streeten DHP: Measurement of osmotic threshold for vasopressin release in human subjects and its modification by Cortisol. J Clin Endocrinol 25:1481–1492, 1965
  44. Green HH, Harrington AR, Valtin H: On the role of antidiuretic hormone in the inhibition of acute water diuresis in adrenal insufficiency and the effects of gluco- and mineralocorticoids in reversing the inhibition. J Clin Invest 49:1724–1736, 1970
  45. Fichman MP, Bethune JE: The role of adrenocorticoids in the inappropriate antidiuretic hormone syndrome. Ann Intern Med 68:806–820, 1968
  46. Schrier RW, Berl T: Nonosmolar factors affecting renal water excretion. N Engl J Med 292:81–88, 141–145, 1975
  47. Moses AM, Miller M: Drug induced dilutional hyponatremia. N Engl J Med 291:1234–1239, 1974
  48. Forrest JN Jr, Singer I: Drug-induced interference with action of antidiuretic hormone, in Disturbances in Body Fluid Osmolality edited by Andreoli T, Grantham JJ, Rector FC Jr, American Physiological Society, 1977, pp. 309–340
  49. Meinders AE, Van Leeuwen AM, Borst GG, Cejka V: Paradoxical diuresis after vasopressin administration to patients with neurohypophyseal diabetes insipidus treated with chlorpropamide, carbamazepine or clofibrate. Clin Sci Mol Med 49:283–290, 1975
  50. Grumer HA, Derryberry W, Dubin A, Walstein SS: Idiopathic, episodic inappropriate secretion of antidiuretic hormone. Am J Med 32:954–963, 1962
  51. Waldvogel F, DeSousa RC, Mach RS: Intoxication a l' eau due à eau sécrétion inadéquate de hormone antidiuretique (syndrome de Schwartz-Bartter) d'origine idiopathique. Schweiz Med Wochenschr 97:929–932, 1967
  52. Skowsky WR, Fisher DA: Intermittent idiopathic inappropriate vasopressin secretion in a child. J Pediatr 83:62–65, 1973
  53. Forrest JN Jr, Cox M, Hong C, Morrison G, Bia M, Singer I: Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 298:173–177, 1978 | PubMed |
  54. Whitaker MD, McArthur RG, Corenblum B, Davidman M, Haslam RH: Idiopathic, sustained, inappropriate secretion of ADH with associated hypertension and thirst. Am J Med 67:511–515, 1979
  55. Denning D, Mace J, Crane M: Hyponatremia and hypertension: a new syndrome. Clin Res 26:169A, 1978
  56. Sherman RL, Susin M, Weksler ME, Ricker E: Lipoid nephrosis in Hodgkin's disease. Am J Med 52:699–706, 1972
  57. Maldonado JE, Velosa JA, Kyle RA, Wagoner RD, Holley KE, Salassa RM: Fanconi syndrome in adults: A manifestation of a latent form of myeloma. Am J Med 58:354–364, 1975
  58. Mellinger RC, Petermann FL, Jurgenson JC: Hyponatremia with low urinary aldosterone occurring in an old woman. J Clin Endocrinol 34:85–91, 1972
  59. Arieff AI, Guisado R: Effects on the central nervous system of hypernatremic and hyponatremic states. Kidney Int 10:104–116, 1976
  60. Swanson AG, Iseri OA: Acute encephalopathy due to water intoxication. N Engl J Med 258:831–834, 1958
  61. Wynn V: Water intoxication and serum hypotonicity. Metabolism 5:490–499, 1956
  62. Arieff AI, Llach F, Massry SG: Neurological manifestations and morbidity of hyponatremia: Correlation with brain water and electrolytes. Medicine 55:121–129, 1976 | PubMed | ISI | ChemPort |
  63. Dila CJ, Pappins HM: Cerebral water and electrolytes: An experimental model of inappropriate secretion of antidiuretic hormone. Arch Neurol 29:85–90, 1972
  64. Hantman D, Rossier B, Zohlman R, Schrier R: Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Ann Intern Med 78:870–875, 1973
  65. Singer I, Forrest JN Jr: Drug-induced states of nephrogenic diabetes insipidus. Kidney Int 10:82–95, 1976
  66. Martinez-Maldonado M, Eknoyan G, Suki WN: Diuretics in non-edematous states: Physiological basis for the clinical use. Arch Intern Med 131:797–802, 1973
  67. Forrest JN Jr, Cohen AD, Torretti J, Himmelhock JM, Epstein FH: On the mechanism of lithium-induced diabetes insipidus in man and the rat. J Clin Invest 53:1115–1123, 1974 | PubMed | ISI | ChemPort |
  68. Solomon S: Action of alkali metals on papillary-cortical sodium gradient of dog kidney. Proc Soc Exp Biol Med 125:1183–1186, 1967
  69. Martinez-Maldonado M, Stavroulaki-Tsapara A, Tsaparas N, Suki WN, Eknoyan G: Renal effects of lithium administration in rats: alterations in water and electrolyte metabolism and the response to vasopressin and cyclic-adenosine monophosphate during prolonged administration. J Lab Clin Med 86:445–461, 1975
  70. Singer I, Franko EA: Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies. J Clin Invest 51:1081–1091, 1972 | PubMed | ChemPort |
  71. Singer I, Franko EA: Lithium-induced ADH resistance in toad urinary bladders. Kidney Int 3:151–159, 1973
  72. Singer I, Rotenberg D: Demeclocycline-induced nephrogenic diabetes insipidus. Ann Intern Med 79:679–683, 1973
  73. Guzzo J, Cox M, Kelley B, Singer I: Tetracycline-induced inhibition of Na+ transport in the toad urinary bladder. Am J Physiol 235:F359–F366, 1978
  74. Feldman HA, Singer I: Comparative effects of tetracyclines on water flow across toad urinary bladders. J Pharmacol Exp Ther 190:358–364, 1974
  75. Dousa TP, Wilson DM: Effect of demethylchlortetracycline on cellular action of antidiuretic hormone in vitro. Kidney Int 5:279–284, 1974
  76. White MG, Fetner CD: Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with lithium carbonate. N Engl J Med 293:915–918, 1975
  77. Cherril DA, Stote RM, Birge JR, Singer I: Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion. Ann Intern Med 83:654–656, 1975
  78. Dias N, Hocken AG: Oliguric renal failure complicating lithium carbonate therapy. Nephron 10:246–249, 1972
  79. Martinez-Maldonado M, Terrel J: Lithium carbonate-induced nephrogenic diabetes insipidus and glucose intolerance. Arch Intern Med 132:881–883, 1973
  80. Hestbech J, Hansen HE, Andisen A, Olsen S: Chronic renal lesions following long term treatment with lithium. Kidney Int 12:205–213, 1977 | PubMed | ISI | ChemPort |
  81. DeTroyer A, Demanet J-C: Correction of antidiuresis by demeclocycline. N Engl J Med 293:915–918, 1975
  82. DeTroyer A: Demeclocycline: treatment of inappropriate antidiuretic hormone secretion. JAMA 237:2723–2726, 1977 | PubMed |
  83. Poupon R, Gustot P, Darnis F: Correction of antidiuresis and sodium retention by demeclocycline in patients with intractable ascites and edema. Digestion 14:472, 1976 (abst)
  84. DeTroyer A, Pilloy W, Bioechaert I: Demeclocycline treatment of water retention in cirrhosis. Ann Intern Med 85:336–337, 1976
  85. Oster JR, Epstein M, Ulano HB: Deterioration of renal function with demeclocycline administration. Curr Therap Res 20:794–801, 1976
  86. Carrilho F, Bosch J, Arroyo V, Mas J, Viver J, Rades J: Renal failure associated with demeclocycline in cirrhosis. Ann Intern Med 87:195–197, 1977
  87. Schrier RW: New treatments for hyponcitremia. N Engl J Med 298:214–215, 1978
  88. Tarray A, Yust I, Peresererrschi G, Abramov AL, Aviram A: Long-term treatment of the syndrome of inappropriate antidiuretic hormone secretion with phenytoin. Ann Intern Med 90:50–52, 1979
  89. Earley LE, Martino JA, Friedler RM: Factors affecting sodium reabsorption by proximal tubule as determined during blockade of distal sodium reabsorption. J Clin Invest 45:1668–1684, 1966
  90. Ladd M: Effect of prehydration upon renal excretion of sodium in man. J Applied Physiol 3:603–609, 1951
  91. Chonko AM, Grantham JJ: The use of the isolated tubule preparation for the investigation of diuretics, in Methods in Pharmacology vol. 4A: Renal Pharmacology, edited by Martinez-Maldonado M, Plenum, 1976, pp. 47–71
  92. Abramow M: Effects of ethacrynic acid on the isolated collecting tubule. J Clin Invest 53:796–804, 1974 | PubMed | ChemPort |
  93. Eknoyan G, Martinez-Maldonado M, Suki WN, Richie Y: Renal diluting capacity in the hypokalemic rat. Am J Physiol 219:933–938, 1970
  94. Relman AS, Schwartz WB: The nephropathy of potassium depletion. N Engl J Med 255:195–203, 1956

Extra navigation

.
ADVERTISEMENT